share_log
Reuters ·  Jan 22 14:20
United Laboratories International - Approval for Clinical Trial of Ubt251 Injection on Indication of Chronic Kidney Disease by Nmpa
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 209

Recommended

Write a comment